These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33529007)

  • 61. Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system.
    Li X; Ji X; Chen K; Yuan X; Lei Z; Ullah MW; Xiao J; Yang G
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111889. PubMed ID: 33579501
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
    Sacco R; Bargellini I; Bertini M; Bozzi E; Romano A; Petruzzi P; Tumino E; Ginanni B; Federici G; Cioni R; Metrangolo S; Bertoni M; Bresci G; Parisi G; Altomare E; Capria A; Bartolozzi C
    J Vasc Interv Radiol; 2011 Nov; 22(11):1545-52. PubMed ID: 21849247
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    Wu X; Chapiro J; Malhotra A; Kothary N
    J Vasc Interv Radiol; 2021 Jan; 32(1):2-12.e1. PubMed ID: 33160827
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
    O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series.
    Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M
    Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
    Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
    Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer.
    Liu F; Li X; Li Y; Qi Y; Yuan H; He J; Li W; Zhou M
    Biomater Sci; 2019 Apr; 7(5):1842-1851. PubMed ID: 30942214
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.
    Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS
    Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spectral CT-Based Iodized Oil Quantification to Predict Tumor Response Following Chemoembolization of Hepatocellular Carcinoma.
    Choi WS; Chang W; Lee M; Hur S; Kim HC; Jae HJ; Chung JW; Choi JW
    J Vasc Interv Radiol; 2021 Jan; 32(1):16-22. PubMed ID: 33162309
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
    Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma.
    Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres.
    Albrecht KC; Aschenbach R; Diamantis I; Eckardt N; Teichgräber U
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):23-32. PubMed ID: 32880029
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
    Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
    J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
    Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictive imaging for tumor response to drug-eluting microsphere transarterial chemoembolization in patients with BCLC-C advanced hepatocellular carcinoma.
    Chang KH; Hwang ZA; Chang PY; Lin HH; Shih YL; Chang WC; Huang GS; Hsu HH
    Sci Rep; 2019 Dec; 9(1):20032. PubMed ID: 31882969
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.
    Shaw CM; Eisenbrey JR; Lyshchik A; O'Kane PL; Merton DA; Machado P; Pino L; Brown DB; Forsberg F
    J Ultrasound Med; 2015 May; 34(5):859-67. PubMed ID: 25911704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.